1. Roy D, for the AF-CHF Investigators. Atrial fibrillation in congestive heart failure trial. Paper presented at: the American Heart Association meeting; November 6, 2007; Orlando, FL.
2. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators;Wyse;N Engl J Med,2002
3. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter;Singh;N Engl J Med,2007
4. Torp-Pedersen C, Roy D, Pratt C, et al. Efficacy and safety of vernakalant (RSD1235 injection) in the treatment of atrial fibrillation: combined analysis of two phase 3 trials. Paper presented at: the European Society of Cardiology World Congress of Cardiology 2006; September 2–6, 2006; Barcelona, Spain.
5. Stiell, I, Roy D, Pratt C. et al. Vernakalant hydrochloride injection (RSD 1235) effectively converts acute atrial fibrillation to sinus rhythm independent of background use of oral rate- or rhythm-control medications. Paper presented at: the 37th Annual Scientific Assembly of the American College of Emergency Physicians; October 15–18, 2006; New Orleans, LA.